I’m looking for education in
Oncology
Webcast
0.50 AMA PRA
Oncology News: nccRCC Edition
Webcast Series
1.00
AMA PRA
Making The Call in Lower-Risk MDS
Webcast
1.00 CME/CE
Hot Topics in Blood-Based Cancer Screening—Volume 2:
Webcast Series
2.50
AMA PRA
Shining a Light on Non-Hodgkin Lymphoma
eHealthSource
1.00 CME/AANP
Multi-Cancer Early Detection
Webcast Series
1.25
CME/CE
Making the Call in Relapsed or Refractory Multiple Myeloma
Webcast
1.00 CME
Can You Compete In Early Cancer Detection?
Webcast
1.50 CME
Staying Vigilant for Immunocompromised Patients
Webcast
1.50 AMA PRA
Testing Your Skills in Blood-Based Multi-Cancer Screening
Webcast
0.50 AMA PRA
Oncology News: nccRCC Edition
A Tailored Approach: Evidence-Based Management Strategies for Advanced/Metastatic ncc-RCC
| Faculty: | Sumanta K. Pal, MD, FASCO; Wesley Yip, MD |
| Release: | 08/28/2024 |
| Expiration: | 08/28/2025 |
Webcast Series
1.00 AMA PRA
Making The Call in Lower-Risk MDS
| Course 1: | Management of newly diagnosed, treatment-naive LR-MDS |
| Course 2: | Management of erythropoiesis-stimulating agent (ESA)-refractory, LR-MDS with RS |
| Course 3: | Management of treatment-naïve LR-MDS |
| Course 4: | Individualized 1L Therapeutic Decision-Making in LR-MDS with Del5Q |
Webcast
1.00 CME/CE
Hot Topics in Blood-Based Cancer Screening—Volume 2:
Updates From Spring 2024 Oncology Conferences
| Faculty: | Gautum Agarwal, MD; Richard A. Whittington, MD |
| Release: | 08/21/2024 |
| Expiration: | 08/21/2025 |
Webcast Series
2.50 AMA PRA
Shining a Light on Non-Hodgkin Lymphoma
| Course 1: | What’s New In Diffuse Large B-Cell Lymphoma |
| Course 2: | What’s New In Follicular Lymphoma |
| Course 3: | What’s New In Mantle Cell Lymphoma |
| Course 4: | What’s New In Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma |
| Course 5: | Hot Topics In Non-Hodgkin Lymphoma |
eHealthSource
1.00 CME/AANP
Multi-Cancer Early Detection
Incorporating Blood-Based Screening Tools into Primary Care Practice
| Faculty: | Candace T. Westgate, DO, MPH, FACOG |
| Release: | 06/17/2024 |
| Expiration: | 06/17/2025 |
Webcast Series
1.25 CME/CE
Making the Call in Relapsed or Refractory Multiple Myeloma
| Course 1: | When and How to Choose Bispecific Antibody Therapy in Relapsed or Refractory Multiple Myeloma |
| Course 2: | Getting Started: Incorporating Bispecifics Into Clinical Practice |
| Course 3: | Monitoring Disease Progression and Deciding When to Initiate Next Line Therapy |
| Course 4: | Multidisciplinary Care in MM: Highlighting the Role of Advanced Practice Providers Caring For Patients Starting BsAb Therapy |
| Course 5: | Multidisciplinary Care in MM: Highlighting the Role of Community Oncologists in Long-term Management of Patients on BsAb Therapy |
Webcast
1.00 CME
Can You Compete In Early Cancer Detection?
Online Activity
| Faculty: | Mylynda B. Massart, MD, PhD; Charles P. Vega, MD, FAAFP; Richard A. Whittington, MD |
| Release: | 12/15/2023 |
| Expiration: | 12/15/2024 |
Webcast
1.50 CME
Staying Vigilant for Immunocompromised Patients
Insights from a COVID-19 Expert Working Group
| Faculty: | Eric S. Daar, MD; Roger J. Bedimo, MD; Brinda Emu, MD |
| Release: | 11/15/2023 |
| Expiration: | 11/15/2024 |
Webcast
1.50 AMA PRA
Testing Your Skills in Blood-Based Multi-Cancer Screening
A CME Jeopardy™ Event
| Faculty: | Mark D. Gomez, MD; Gautum Agarwal, MD; Mylynda B. Massart, MD, PhD |
| Release: | 09/27/2024 |
| Expiration: | 10/25/2024 |
